We have target-specific selection platforms and teams with refined, efficient workflows built to prevent reagent development from limiting your programmes. Clear milestones are incorporated into our workflow to help mitigate risk. We work in a data-driven fashion offering the flexibility to direct and adapt the custom Optimer process to achieve the right solution for each unique project.
Optimers have been successfully developed for a range of applications, including:
Understanding of customer needs and project aims.
Work schedule developed following established, standardised approach to meet clear milestones via data-driven model.
Delivers rapid insight into project feasibility for quick go/no-go decisions.
Wide range of viable targets:
proteins and peptides (immunoglobulins, serum proteins, membrane proteins, secreted proteins, enzymes, specific protein domains, peptides >20 kDa)
cells (fixed and live cells in suspension and monolayer culture)
small molecules (drugs, toxins, food additives, environmental contaminants)
Targets and counter-targets are tested for purity, concentration and optimal buffer compatibility for the selection process.
Specific proprietary high-throughput selection processes for different target classes:
Cells
Proteins and peptides
Small molecules
Adaptable selection system with the ability to: counter-select against related targets, select in end-use buffer and matrix conditions, select in the presence/ absence of ligands, screen mutant vs wild-type, select for specific binding kinetics and performance.
Aptamer pools are assessed for target affinity and the aptamer population is cloned out
Individual clones isolated from the population for next-generation sequencing to determine the diversity in the aptamer repertoire.
Individual aptamers ranked according to target affinity by biolayer interferometry or other project-defined criteria.
Target affinity of the best aptamer clone is increased and cost-effective manufacture ensured via identification of the minimal performing fragment of the aptamer to generate an Optimer.
Optional services from proof-of-concept to a defined and functional assay.
Range of assays available in-house, including; ELISA, flow cytometry, cell-based inhibition/activation assays, affinity chromatography, WB, SPR, fluorescence microscopy and IHC.
Sequencing, synthesis and quality control processes to ensure delivery of a functional aptamer.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.